Clinical Trial

Multiple Myeloma Molecular Monitoring Study

Study acronym: M4
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The investigators will track 250 multiple myeloma patients across Canada over time, using new lab tests to evaluate their blood and bone marrow, as they receive standard of care treatment. The main hypothesis is that these tests will allow clinicians to better diagnose and manage multiple myeloma, improving patients' quality of life overall.
Protocol Amendment History 14 amendments
This ClinicalTrials.gov record has been amended 14 times since 2018-02-01; most recent amendment 2025-06-25.
Status change: Recruiting → Active, Not Recruiting 2024-02-27
Status change: Not Yet Recruiting → Recruiting 2018-04-04
Trial Details
NCT Number NCT03421132
Lead Sponsor Horizon Health Network
Conditions Multiple Myeloma
Enrollment 96 participants
Start Date 2018-02-20
Primary Completion 2024-12-31 (estimated)
Study Completion 2026-03-31 (estimated)
Updated on ClinicalTrials.gov 2025-06-29